← Back to Search

Resistance vs Endurance Exercise for Osteoporosis (MOVE Trial)

N/A
Recruiting
Led By Sarah J Wherry, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Fracture in the past 6 months
History of type 1 or type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up serum ica is measured before exercise (-15, 0 minutes) and after exercise (60, 120, 300 minutes and 24 and 48 hours),
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare how two types of exercise affect bone resorption in adults. It is not known if resistance exercise causes a similar increase in bone resorption as endurance exercise, or if exercise training affects the increase in bone resorption following exercise for both endurance and resistance exercise.

Who is the study for?
This trial is for healthy older veterans aged 60+ in the Denver area who are normally active, like walking or cycling. They can't join if they have liver disease, kidney problems, anemia, diabetes, thyroid issues, abnormal calcium levels, severe high blood pressure, recent COVID-19 symptoms or diagnosis, a fracture within the last six months or heart disease.
What is being tested?
The study tests how two types of exercise affect bone health markers in older adults. Participants will do either 10 weeks of supervised resistance training (like lifting weights) or endurance training (like running), to see which one is better for bones.
What are the potential side effects?
While not explicitly stated for this trial since it's about exercise interventions rather than medications; potential side effects may include muscle soreness and fatigue from resistance exercises and joint impact concerns from endurance activities.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a bone break in the last 6 months.
Select...
I have a history of diabetes (type 1 or 2).
Select...
My kidney function is reduced, with an eGFR below 60.
Select...
I am currently diagnosed with or showing symptoms of COVID-19.
Select...
My liver tests are higher than normal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~serum tca is measured before exercise (-15, 0 minutes) and after exercise (60, 120, 300 minutes and 24 and 48 hours).
This trial's timeline: 3 weeks for screening, Varies for treatment, and serum tca is measured before exercise (-15, 0 minutes) and after exercise (60, 120, 300 minutes and 24 and 48 hours). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
6-minute walk test
Procollagen 1 intact N-terminal propeptide (P1NP)
Short Physical Performance Battery (SPPB)
+1 more
Secondary study objectives
Ionized calcium (iCa)
Parathyroid Hormone (PTH)
Total calcium (tCa)
Other study objectives
1-repetition maximum (1RM)
VO2peak from graded exercise test (GXT)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Resistance ExerciseExperimental Treatment1 Intervention
Participants will perform total body resistance training 3x per week for 10 weeks. Each exercise session will last approximately 1 hour.
Group II: Endurance ExerciseExperimental Treatment1 Intervention
Participants will complete 60 minutes of stationary cycling 3x per week at 70-80% of maximal heart rate for 10 weeks.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,605 Total Patients Enrolled
University of Colorado, DenverOTHER
1,806 Previous Clinical Trials
2,822,757 Total Patients Enrolled
Sarah J Wherry, PhDPrincipal InvestigatorRocky Mountain Regional VA Medical Center, Aurora, CO
3 Previous Clinical Trials
85 Total Patients Enrolled

Media Library

10 Weeks of Supervised Endurance Exercise Training Clinical Trial Eligibility Overview. Trial Name: NCT05266976 — N/A
Musculoskeletal Disorders Research Study Groups: Resistance Exercise, Endurance Exercise
Musculoskeletal Disorders Clinical Trial 2023: 10 Weeks of Supervised Endurance Exercise Training Highlights & Side Effects. Trial Name: NCT05266976 — N/A
10 Weeks of Supervised Endurance Exercise Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05266976 — N/A
~55 spots leftby Dec 2026